nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.216	0.279	CbGbCtD
Scopolamine—ABCB1—Betamethasone—ankylosing spondylitis	0.14	0.182	CbGbCtD
Scopolamine—ABCB1—Prednisolone—ankylosing spondylitis	0.139	0.179	CbGbCtD
Scopolamine—ABCB1—Prednisone—ankylosing spondylitis	0.131	0.169	CbGbCtD
Scopolamine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0817	0.106	CbGbCtD
Scopolamine—ABCB1—Methotrexate—ankylosing spondylitis	0.0656	0.0849	CbGbCtD
Scopolamine—Drug withdrawal syndrome—Methylprednisolone—ankylosing spondylitis	0.00577	0.0255	CcSEcCtD
Scopolamine—Drug withdrawal syndrome—Dexamethasone—ankylosing spondylitis	0.00525	0.0232	CcSEcCtD
Scopolamine—Drug withdrawal syndrome—Betamethasone—ankylosing spondylitis	0.00525	0.0232	CcSEcCtD
Scopolamine—Drug withdrawal syndrome—Prednisone—ankylosing spondylitis	0.00457	0.0202	CcSEcCtD
Scopolamine—Mydriasis—Prednisolone—ankylosing spondylitis	0.00387	0.0171	CcSEcCtD
Scopolamine—Dry eye—Dexamethasone—ankylosing spondylitis	0.00238	0.0105	CcSEcCtD
Scopolamine—Dry eye—Betamethasone—ankylosing spondylitis	0.00238	0.0105	CcSEcCtD
Scopolamine—Amnesia—Methylprednisolone—ankylosing spondylitis	0.00219	0.00965	CcSEcCtD
Scopolamine—Speech disorder—Methotrexate—ankylosing spondylitis	0.00218	0.00961	CcSEcCtD
Scopolamine—Dry skin—Prednisolone—ankylosing spondylitis	0.00205	0.00906	CcSEcCtD
Scopolamine—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00201	0.00886	CcSEcCtD
Scopolamine—Muscular weakness—Prednisolone—ankylosing spondylitis	0.00198	0.00872	CcSEcCtD
Scopolamine—Irritability—Methylprednisolone—ankylosing spondylitis	0.00196	0.00866	CcSEcCtD
Scopolamine—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00183	0.00805	CcSEcCtD
Scopolamine—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00183	0.00805	CcSEcCtD
Scopolamine—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00182	0.00802	CcSEcCtD
Scopolamine—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.00181	0.008	CcSEcCtD
Scopolamine—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.00181	0.00798	CcSEcCtD
Scopolamine—Irritability—Dexamethasone—ankylosing spondylitis	0.00178	0.00787	CcSEcCtD
Scopolamine—Irritability—Betamethasone—ankylosing spondylitis	0.00178	0.00787	CcSEcCtD
Scopolamine—Amnesia—Prednisone—ankylosing spondylitis	0.00173	0.00764	CcSEcCtD
Scopolamine—Dry skin—Dexamethasone—ankylosing spondylitis	0.00171	0.00756	CcSEcCtD
Scopolamine—Dry skin—Betamethasone—ankylosing spondylitis	0.00171	0.00756	CcSEcCtD
Scopolamine—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00168	0.0074	CcSEcCtD
Scopolamine—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00165	0.00727	CcSEcCtD
Scopolamine—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00165	0.00727	CcSEcCtD
Scopolamine—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00159	0.00701	CcSEcCtD
Scopolamine—Bradycardia—Prednisolone—ankylosing spondylitis	0.00158	0.00696	CcSEcCtD
Scopolamine—Irritability—Prednisone—ankylosing spondylitis	0.00155	0.00686	CcSEcCtD
Scopolamine—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.00154	0.00681	CcSEcCtD
Scopolamine—Sweating—Methylprednisolone—ankylosing spondylitis	0.00152	0.0067	CcSEcCtD
Scopolamine—Visual impairment—Prednisolone—ankylosing spondylitis	0.00149	0.00659	CcSEcCtD
Scopolamine—Dry skin—Prednisone—ankylosing spondylitis	0.00149	0.00658	CcSEcCtD
Scopolamine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00145	0.0064	CcSEcCtD
Scopolamine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00145	0.00639	CcSEcCtD
Scopolamine—Muscular weakness—Prednisone—ankylosing spondylitis	0.00144	0.00633	CcSEcCtD
Scopolamine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00142	0.00624	CcSEcCtD
Scopolamine—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00141	0.00624	CcSEcCtD
Scopolamine—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.0014	0.00618	CcSEcCtD
Scopolamine—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.0014	0.00618	CcSEcCtD
Scopolamine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00138	0.00611	CcSEcCtD
Scopolamine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00137	0.00605	CcSEcCtD
Scopolamine—Erythema—Prednisolone—ankylosing spondylitis	0.00135	0.00595	CcSEcCtD
Scopolamine—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00133	0.00586	CcSEcCtD
Scopolamine—Bradycardia—Betamethasone—ankylosing spondylitis	0.00132	0.00581	CcSEcCtD
Scopolamine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00132	0.00581	CcSEcCtD
Scopolamine—Irritability—Methotrexate—ankylosing spondylitis	0.0013	0.00573	CcSEcCtD
Scopolamine—Hallucination—Dexamethasone—ankylosing spondylitis	0.00129	0.00568	CcSEcCtD
Scopolamine—Hallucination—Betamethasone—ankylosing spondylitis	0.00129	0.00568	CcSEcCtD
Scopolamine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00127	0.00562	CcSEcCtD
Scopolamine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00127	0.00561	CcSEcCtD
Scopolamine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00127	0.0056	CcSEcCtD
Scopolamine—Visual impairment—Betamethasone—ankylosing spondylitis	0.00125	0.0055	CcSEcCtD
Scopolamine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00125	0.0055	CcSEcCtD
Scopolamine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00125	0.0055	CcSEcCtD
Scopolamine—Erythema—Triamcinolone—ankylosing spondylitis	0.00124	0.00547	CcSEcCtD
Scopolamine—Erythema—Methylprednisolone—ankylosing spondylitis	0.00124	0.00546	CcSEcCtD
Scopolamine—Vertigo—Prednisolone—ankylosing spondylitis	0.00121	0.00535	CcSEcCtD
Scopolamine—Eye disorder—Betamethasone—ankylosing spondylitis	0.00121	0.00533	CcSEcCtD
Scopolamine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00121	0.00533	CcSEcCtD
Scopolamine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00116	0.0051	CcSEcCtD
Scopolamine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00116	0.0051	CcSEcCtD
Scopolamine—Bradycardia—Prednisone—ankylosing spondylitis	0.00115	0.00506	CcSEcCtD
Scopolamine—Erythema—Dexamethasone—ankylosing spondylitis	0.00113	0.00497	CcSEcCtD
Scopolamine—Erythema—Betamethasone—ankylosing spondylitis	0.00113	0.00497	CcSEcCtD
Scopolamine—Hallucination—Prednisone—ankylosing spondylitis	0.00112	0.00494	CcSEcCtD
Scopolamine—Vertigo—Triamcinolone—ankylosing spondylitis	0.00111	0.00492	CcSEcCtD
Scopolamine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00111	0.00491	CcSEcCtD
Scopolamine—Oedema—Prednisolone—ankylosing spondylitis	0.0011	0.00486	CcSEcCtD
Scopolamine—Dysuria—Methotrexate—ankylosing spondylitis	0.0011	0.00485	CcSEcCtD
Scopolamine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00107	0.00474	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00106	0.0047	CcSEcCtD
Scopolamine—Eye disorder—Prednisone—ankylosing spondylitis	0.00105	0.00464	CcSEcCtD
Scopolamine—Drowsiness—Methotrexate—ankylosing spondylitis	0.00105	0.00463	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00105	0.00462	CcSEcCtD
Scopolamine—Flushing—Prednisone—ankylosing spondylitis	0.00105	0.00461	CcSEcCtD
Scopolamine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00103	0.00456	CcSEcCtD
Scopolamine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00102	0.0045	CcSEcCtD
Scopolamine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00102	0.00449	CcSEcCtD
Scopolamine—Oedema—Triamcinolone—ankylosing spondylitis	0.00101	0.00447	CcSEcCtD
Scopolamine—Vertigo—Dexamethasone—ankylosing spondylitis	0.00101	0.00446	CcSEcCtD
Scopolamine—Vertigo—Betamethasone—ankylosing spondylitis	0.00101	0.00446	CcSEcCtD
Scopolamine—Arrhythmia—Prednisone—ankylosing spondylitis	0.00101	0.00444	CcSEcCtD
Scopolamine—Sweating—Methotrexate—ankylosing spondylitis	0.00101	0.00443	CcSEcCtD
Scopolamine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000991	0.00437	CcSEcCtD
Scopolamine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000988	0.00436	CcSEcCtD
Scopolamine—Mental disorder—Prednisone—ankylosing spondylitis	0.000987	0.00435	CcSEcCtD
Scopolamine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000986	0.00435	CcSEcCtD
Scopolamine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000981	0.00433	CcSEcCtD
Scopolamine—Erythema—Prednisone—ankylosing spondylitis	0.00098	0.00433	CcSEcCtD
Scopolamine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000979	0.00432	CcSEcCtD
Scopolamine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000977	0.00431	CcSEcCtD
Scopolamine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000944	0.00417	CcSEcCtD
Scopolamine—Pain—Prednisolone—ankylosing spondylitis	0.000942	0.00415	CcSEcCtD
Scopolamine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000934	0.00412	CcSEcCtD
Scopolamine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00093	0.0041	CcSEcCtD
Scopolamine—Vision blurred—Prednisone—ankylosing spondylitis	0.000924	0.00408	CcSEcCtD
Scopolamine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000923	0.00407	CcSEcCtD
Scopolamine—Oedema—Dexamethasone—ankylosing spondylitis	0.000919	0.00405	CcSEcCtD
Scopolamine—Oedema—Betamethasone—ankylosing spondylitis	0.000919	0.00405	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000907	0.004	CcSEcCtD
Scopolamine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000907	0.004	CcSEcCtD
Scopolamine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000901	0.00398	CcSEcCtD
Scopolamine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000901	0.00398	CcSEcCtD
Scopolamine—Agitation—Prednisone—ankylosing spondylitis	0.000901	0.00397	CcSEcCtD
Scopolamine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000897	0.00396	CcSEcCtD
Scopolamine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000897	0.00396	CcSEcCtD
Scopolamine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000888	0.00392	CcSEcCtD
Scopolamine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000888	0.00392	CcSEcCtD
Scopolamine—Vertigo—Prednisone—ankylosing spondylitis	0.000881	0.00389	CcSEcCtD
Scopolamine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00088	0.00388	CcSEcCtD
Scopolamine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000873	0.00385	CcSEcCtD
Scopolamine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000871	0.00384	CcSEcCtD
Scopolamine—Pain—Triamcinolone—ankylosing spondylitis	0.000866	0.00382	CcSEcCtD
Scopolamine—Hypotension—Betamethasone—ankylosing spondylitis	0.000859	0.00379	CcSEcCtD
Scopolamine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000859	0.00379	CcSEcCtD
Scopolamine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000834	0.00368	CcSEcCtD
Scopolamine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000833	0.00367	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000829	0.00366	CcSEcCtD
Scopolamine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000825	0.00364	CcSEcCtD
Scopolamine—Erythema—Methotrexate—ankylosing spondylitis	0.000819	0.00361	CcSEcCtD
Scopolamine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000801	0.00353	CcSEcCtD
Scopolamine—Oedema—Prednisone—ankylosing spondylitis	0.0008	0.00353	CcSEcCtD
Scopolamine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000799	0.00352	CcSEcCtD
Scopolamine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000792	0.00349	CcSEcCtD
Scopolamine—Fatigue—Betamethasone—ankylosing spondylitis	0.000792	0.00349	CcSEcCtD
Scopolamine—Pain—Betamethasone—ankylosing spondylitis	0.000786	0.00347	CcSEcCtD
Scopolamine—Pain—Dexamethasone—ankylosing spondylitis	0.000786	0.00347	CcSEcCtD
Scopolamine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000785	0.00346	CcSEcCtD
Scopolamine—Tachycardia—Prednisone—ankylosing spondylitis	0.000781	0.00345	CcSEcCtD
Scopolamine—Skin disorder—Prednisone—ankylosing spondylitis	0.000777	0.00343	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000774	0.00341	CcSEcCtD
Scopolamine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000772	0.00341	CcSEcCtD
Scopolamine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000757	0.00334	CcSEcCtD
Scopolamine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000757	0.00334	CcSEcCtD
Scopolamine—Vertigo—Methotrexate—ankylosing spondylitis	0.000736	0.00325	CcSEcCtD
Scopolamine—Dizziness—Prednisolone—ankylosing spondylitis	0.000728	0.00321	CcSEcCtD
Scopolamine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000727	0.00321	CcSEcCtD
Scopolamine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000726	0.0032	CcSEcCtD
Scopolamine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000726	0.0032	CcSEcCtD
Scopolamine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000726	0.0032	CcSEcCtD
Scopolamine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000726	0.0032	CcSEcCtD
Scopolamine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000725	0.0032	CcSEcCtD
Scopolamine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000716	0.00316	CcSEcCtD
Scopolamine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000715	0.00315	CcSEcCtD
Scopolamine—Rash—Prednisolone—ankylosing spondylitis	0.000694	0.00306	CcSEcCtD
Scopolamine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000694	0.00306	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000693	0.00306	CcSEcCtD
Scopolamine—Fatigue—Prednisone—ankylosing spondylitis	0.00069	0.00304	CcSEcCtD
Scopolamine—Headache—Prednisolone—ankylosing spondylitis	0.00069	0.00304	CcSEcCtD
Scopolamine—Constipation—Prednisone—ankylosing spondylitis	0.000684	0.00302	CcSEcCtD
Scopolamine—Confusional state—Methotrexate—ankylosing spondylitis	0.000674	0.00297	CcSEcCtD
Scopolamine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00067	0.00295	CcSEcCtD
Scopolamine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000668	0.00295	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000659	0.00291	CcSEcCtD
Scopolamine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000659	0.00291	CcSEcCtD
Scopolamine—Asthenia—Betamethasone—ankylosing spondylitis	0.000659	0.00291	CcSEcCtD
Scopolamine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000656	0.00289	CcSEcCtD
Scopolamine—Nausea—Prednisolone—ankylosing spondylitis	0.000654	0.00289	CcSEcCtD
Scopolamine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00065	0.00287	CcSEcCtD
Scopolamine—Pruritus—Betamethasone—ankylosing spondylitis	0.00065	0.00287	CcSEcCtD
Scopolamine—Skin disorder—Methotrexate—ankylosing spondylitis	0.00065	0.00287	CcSEcCtD
Scopolamine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000646	0.00285	CcSEcCtD
Scopolamine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000644	0.00284	CcSEcCtD
Scopolamine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000642	0.00283	CcSEcCtD
Scopolamine—Rash—Triamcinolone—ankylosing spondylitis	0.000638	0.00282	CcSEcCtD
Scopolamine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000638	0.00281	CcSEcCtD
Scopolamine—Rash—Methylprednisolone—ankylosing spondylitis	0.000637	0.00281	CcSEcCtD
Scopolamine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000636	0.00281	CcSEcCtD
Scopolamine—Headache—Triamcinolone—ankylosing spondylitis	0.000634	0.0028	CcSEcCtD
Scopolamine—Headache—Methylprednisolone—ankylosing spondylitis	0.000633	0.00279	CcSEcCtD
Scopolamine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000633	0.00279	CcSEcCtD
Scopolamine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000633	0.00279	CcSEcCtD
Scopolamine—Hypotension—Methotrexate—ankylosing spondylitis	0.000625	0.00276	CcSEcCtD
Scopolamine—Dizziness—Betamethasone—ankylosing spondylitis	0.000608	0.00268	CcSEcCtD
Scopolamine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000608	0.00268	CcSEcCtD
Scopolamine—Nausea—Triamcinolone—ankylosing spondylitis	0.000601	0.00265	CcSEcCtD
Scopolamine—Nausea—Methylprednisolone—ankylosing spondylitis	0.0006	0.00265	CcSEcCtD
Scopolamine—Somnolence—Methotrexate—ankylosing spondylitis	0.000595	0.00262	CcSEcCtD
Scopolamine—Vomiting—Betamethasone—ankylosing spondylitis	0.000584	0.00258	CcSEcCtD
Scopolamine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000584	0.00258	CcSEcCtD
Scopolamine—Rash—Betamethasone—ankylosing spondylitis	0.000579	0.00256	CcSEcCtD
Scopolamine—Rash—Dexamethasone—ankylosing spondylitis	0.000579	0.00256	CcSEcCtD
Scopolamine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000579	0.00255	CcSEcCtD
Scopolamine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000579	0.00255	CcSEcCtD
Scopolamine—Fatigue—Methotrexate—ankylosing spondylitis	0.000577	0.00254	CcSEcCtD
Scopolamine—Headache—Betamethasone—ankylosing spondylitis	0.000576	0.00254	CcSEcCtD
Scopolamine—Headache—Dexamethasone—ankylosing spondylitis	0.000576	0.00254	CcSEcCtD
Scopolamine—Asthenia—Prednisone—ankylosing spondylitis	0.000574	0.00253	CcSEcCtD
Scopolamine—Pain—Methotrexate—ankylosing spondylitis	0.000572	0.00252	CcSEcCtD
Scopolamine—Pruritus—Prednisone—ankylosing spondylitis	0.000566	0.0025	CcSEcCtD
Scopolamine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000551	0.00243	CcSEcCtD
Scopolamine—Nausea—Betamethasone—ankylosing spondylitis	0.000546	0.00241	CcSEcCtD
Scopolamine—Nausea—Dexamethasone—ankylosing spondylitis	0.000546	0.00241	CcSEcCtD
Scopolamine—Dizziness—Prednisone—ankylosing spondylitis	0.000529	0.00233	CcSEcCtD
Scopolamine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000529	0.00233	CcSEcCtD
Scopolamine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000529	0.00233	CcSEcCtD
Scopolamine—Vomiting—Prednisone—ankylosing spondylitis	0.000509	0.00224	CcSEcCtD
Scopolamine—Rash—Prednisone—ankylosing spondylitis	0.000505	0.00223	CcSEcCtD
Scopolamine—Dermatitis—Prednisone—ankylosing spondylitis	0.000504	0.00222	CcSEcCtD
Scopolamine—Headache—Prednisone—ankylosing spondylitis	0.000501	0.00221	CcSEcCtD
Scopolamine—Asthenia—Methotrexate—ankylosing spondylitis	0.00048	0.00212	CcSEcCtD
Scopolamine—Nausea—Prednisone—ankylosing spondylitis	0.000475	0.0021	CcSEcCtD
Scopolamine—Pruritus—Methotrexate—ankylosing spondylitis	0.000473	0.00209	CcSEcCtD
Scopolamine—Dizziness—Methotrexate—ankylosing spondylitis	0.000442	0.00195	CcSEcCtD
Scopolamine—Vomiting—Methotrexate—ankylosing spondylitis	0.000425	0.00188	CcSEcCtD
Scopolamine—Rash—Methotrexate—ankylosing spondylitis	0.000422	0.00186	CcSEcCtD
Scopolamine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000421	0.00186	CcSEcCtD
Scopolamine—Headache—Methotrexate—ankylosing spondylitis	0.000419	0.00185	CcSEcCtD
Scopolamine—Nausea—Methotrexate—ankylosing spondylitis	0.000397	0.00175	CcSEcCtD
